Answers are grounded in this paper and cite their sources.
Digital health technologies (DHT) offer the ability to deliver personalized care, lower barriers to access, and positively impact health outcomes. However, DHT utilization is impacted by insufficient market access pathways. A policy "full-stack"—including regulatory authorization, product value assessment, pricing and reimbursement, and patient access infrastructure—offers a framework for DHT integration into national healthcare ecosystems. Consistent clinical evidence requirements across national jurisdictions will further increase DHT scalability.
No takes yet. Share an insight, caveat, or question.
Coder et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: